The Inca thrombolysis catheter with protection filter is an INVAMED device designed to deliver thrombolytic agents directly into a clot while incorporating filter protection intended to reduce the risk of distal embolization. This overview outlines the device's design intent for clinicians evaluating catheter-directed thrombolysis (CDT) options for DVT.
What Is the Inca Thrombolysis Catheter?
Inca is a catheter-based system engineered to combine two functions in a single device: localized delivery of thrombolytic medication into thrombus, and an integrated protection filter intended to help capture fragmented clot material before it can travel downstream. This combined design is intended to support safer pharmacologic clot dissolution compared to thrombolytic infusion without distal protection.
How Is the Device Designed to Work?
During a typical procedure, the catheter is advanced to the treatment site under imaging guidance. The thrombolytic-delivery function allows the operator to infuse medication directly at or within the clot, aiming to achieve higher local drug concentration while potentially reducing the systemic dose required. The integrated protection filter is designed to sit distal to the treatment zone, intended to reduce the likelihood that dislodged clot fragments travel further into the venous system or toward the lungs during the dissolution process.
What Are the Key Design Features?
- Dual-function catheter — combines thrombolytic drug delivery with distal filter protection in one device
- Localized infusion design — intended to concentrate thrombolytic therapy at the clot site
- Filter protection element — engineered to help reduce distal embolization risk during pharmacologic lysis
- Catheter-based delivery — designed for percutaneous, image-guided placement
Where Does Inca Fit Within DVT Management?
Inca is positioned within the catheter-directed thrombolysis category of DVT interventions, offering an option for clinicians who want to combine targeted pharmacologic clot dissolution with an added layer of embolization protection. It may be considered alongside purely mechanical platforms such as Mantis or ultrasonic-assisted systems such as Viper, depending on clot characteristics and the clinical scenario. As with all thrombolytic-based procedures, bleeding risk and contraindications to thrombolytic therapy must be assessed individually by the treating physician.
Frequently Asked Questions
What is catheter-directed thrombolysis?
Catheter-directed thrombolysis (CDT) delivers thrombolytic drugs directly into a clot through a catheter, aiming to achieve higher local drug concentration with a comparatively lower systemic dose, which may help reduce bleeding risk relative to systemic thrombolytic administration.
Why does the Inca catheter include a protection filter?
The integrated filter is designed to help reduce the risk that fragmented clot material dislodges and travels further into the venous system or toward the lungs during thrombolytic infusion, adding a safety-oriented design element to the CDT process.
Is thrombolytic therapy appropriate for every DVT patient?
No. Thrombolytic therapy carries bleeding risk and is contraindicated in certain clinical situations. Candidacy is determined by a physician based on an individualized risk-benefit assessment.
Related INVAMED Resources
- Deep Vein Thrombosis (DVT) Product Portfolio
- Pulmonary Embolism Management
- Request Information from INVAMED
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.